$400 Member/$500 Non-Member

Recorded at AIHce EXP 2023

Asbestos and nanoparticles have a lot of differences, but also, a lot in common as toxic agents. Both types of toxicants are invisible, small-size particles able to penetrate deep into human respiratory system causing carcinogenic and noncarcinogenic effects. While all types of asbestos are carcinogenic, not all nanoparticles may cause cancer. Asbestos provides important lessons for assessing the risks from nanoparticle exposures. The PDC will introduce the audience into the topic of quantitative risk assessment of nanoparticles with asbestos in comparison; to derive practical recommendations for dealing with workplace and community exposures. This course will present the following topics: 1) toxicology of asbestos and nanoparticles; 2) metrics and methods for exposure assessment; 3) dose-response relationships for nanoparticles; 4) predicting various health outcomes of exposure; 5) practical exposure control recommendations; 6) naturally occurring elongate mineral particles (EMPs); and 7) hands-on exercises with sampling equipment. The participants will be able to discuss the risk assessment process with the presenters who have published on asbestos and nanoparticles exposure assessment and toxicology.

Attendees will receive handouts containing methodological approaches and recommendations for controlling exposures to nanoparticles.

Course outline

  • Introduction
  • Principles of Quantitative Risk Assessment
  • Nanoparticles and Asbestos: Types and Toxicity Characteristics
  • Asbestos Exposure assessment: Airborne, Bulk, and Surface Sampling
  • Nanoparticles Exposure assessment: Methods and Equipment
  • Dose-Response for Carcinogenic Effects: Quantitative Models
  • Risk Characterization and Management of Exposure: Workers' Protection Program
  • Risk Communication for Workers and Communities
  • Review of the Learning Outcomes, Questions and Answers

    Course outcomes

    Upon completion, students will be able to:

    • Discuss the various types of asbestos and nanoparticles.
    • Recognize the sources of asbestos and nanoparticles exposure.
    • Describe the toxicity characteristics of nanoparticles.
    • Select appropriate exposure assessment methods and equipment.
    • Compare dose-response models for carcinogenic risk assessment.
    • Develop risk criteria for workplace nanoparticle exposures.
    • Characterize risk for workers and communities using exposure data and modelling results.
    • Communicate the quantitative risk assessment results to the stakeholders.

    Time to complete

    Participants will have 90 days from the date of purchase to view the session recordings and submit the online evaluation for credit.


    Have questions or need additional information? Contact us.